missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies AZD8055

mTOR pathway inhibitor; Inhibits mTOR

75.60€ - 145.80€

Specifications

CAS 1009298-09-2
Synonym CCG-168
Molecular Formula C25H31N5O4
Purity ≥98%
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17100162
Encompass_Preferred
View Documents
STEMCELL Technologies
73002
1 mg
75.60€
1mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17110162
Encompass_Preferred
View Documents
STEMCELL Technologies
73004
10 mg
145.80€
10mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

  • AZD8055 is a potent, selective ATP-competitive inhibitor of mammalian target of rapamycin (mTOR), with an IC50 value of 0.8 nM (Chresta et al.) It is very specific with ∼1,000-fold selectivity for mTOR over all PI3K isoforms and exhibits no activity against a panel of 260 kinases at concentrations up to 10 μM (Chresta et al.)
Specifications

Specifications

1009298-09-2
CCG-168
C25H31N5O4
≥98%
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.